Retinopathy Stocks List
|OCUP||F||Ocuphire Pharma, Inc.||-9.26|
|ARPO||F||Aerpio Pharmaceuticals, Inc.||-3.95|
|KOD||D||Kodiak Sciences Inc||-2.77|
|APLT||F||Applied Therapeutics, Inc.||-1.33|
|GRAY||F||Graybug Vision, Inc.||-0.91|
|QMOM||D||MomentumShares U.S. Quantitative Momentum ETF||2.12|
|IBBJ||F||Defiance Nasdaq Junior Biotechnology ETF||1.8|
|BBC||D||Virtus LifeSci Biotech Clinical Trials ETF||0.98|
|XBI||F||SPDR Series Trust SPDR S&P Biotech ETF||0.84|
|BTEC||C||Principal Healthcare Innovators Index ETF||0.81|
View all Retinopathy related ETFs...
Retinopathy is any damage to the retina of the eyes, which may cause vision impairment. Retinopathy often refers to retinal vascular disease, or damage to the retina caused by abnormal blood flow. Age-related macular degeneration is technically included under the umbrella term retinopathy but is often discussed as a separate entity. Retinopathy, or retinal vascular disease, can be broadly categorized into proliferative and non-proliferative types. Frequently, retinopathy is an ocular manifestation of systemic disease as seen in diabetes or hypertension. Diabetes is the most common cause of retinopathy in the U.S. as of 2008. Diabetic retinopathy is the leading cause of blindness in working-aged people. It accounts for about 5% of blindness worldwide and is designated a priority eye disease by the World Health Organization.